
Annalise.ai
Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model
- Web
- Self-hosted
3 alternatives · 4 questions answered
The directory
7 products matching your filters. Each one described on the same fields, so two tools can be read against each other rather than against their own marketing.
Showing 1–7 of 7

Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model
3 alternatives · 4 questions answered

CE marked and FDA cleared imaging AI suite for bone trauma and chest, now owned by RadNet
3 alternatives · 4 questions answered

Cancer detection AI for breast, prostate and gastric pathology deployed in routine clinical service, not just pilots
3 alternatives · 4 questions answered

Clinical trial EDC with a genuinely open source community edition alongside a quoted commercial platform
4 questions answered · 5 limitations documented

Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus
3 alternatives · 4 questions answered

Enterprise imaging and PACS from a Swedish vendor that also sells the pathology and cardiology modules on one platform
3 alternatives · 4 questions answered

Haematology and urinalysis analysers sold with the middleware that decides which results a scientist ever sees
3 alternatives · 4 questions answered
Head to head
Pairings from this slice of the directory, each one checked by two reviewers who agreed a buyer would weigh the two against each other.
Browse another way
How this works
Pricing, platforms and feature lists are taken from each vendor's own pages. Limitations, answered questions and alternatives are researched separately and carry a source URL on the page that states them. Every product is described on the same fields, so two tools can be read against each other rather than against their own marketing.
Because we did not collect any. Softwr hosts no reviews, and a rating aggregated from somewhere else is not ours to publish as though it were an assessment we made. What is shown instead is what a tool costs, where it runs, and what it is concretely bad at.
A researcher proposes them, then two independent reviewers judge one question each: would a buyer evaluating this product seriously consider that one instead. 225 of 1,841 candidates failed and were deleted, including a font inspector matched to a dark mode extension. Only pairings that survived both rounds are published.
Not to be listed. A vendor can buy a place in the results on the home page, on a category listing or on the catalogue, and where they do the result carries a Sponsored label. Everything not carrying that label is ordered on the same criteria as everything else, and a paid place never changes where an unpaid one lands: the editorial order flows around it. Where a link earns a commission that is disclosed on the page carrying it.
Prices and plan limits move without notice, so treat anything with a number on it as a starting point and check the vendor before you buy. Where a claim could go stale it carries the source it came from, which is the fastest way to tell.
Something missing here?
Anyone can submit a tool. A person reads every submission, checks the pricing against the vendor’s own page, and nothing is published until it passes.